Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts

Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Yip, B, Vuppusetty, C, Attwood, M, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, MacIejewski, J, Vandenberghe, P, Mecucci, C, Wainscoat, J, Pellagatti, A, Boultwood, J
Format:	Journal article
Język:	English
Wydane:	2013

Podobne zapisy

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
od: Yip, B, i wsp.
Wydane: (2013)

Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells
od: Yip, B, i wsp.
Wydane: (2012)

Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
od: Yip, B, i wsp.
Wydane: (2012)

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
od: Yip, B, i wsp.
Wydane: (2012)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
od: Boultwood, J, i wsp.
Wydane: (2013)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
od: Bello, E, i wsp.
Wydane: (2018)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
od: Erica Bello, i wsp.
Wydane: (2018-11-01)

Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF
od: Nikpour, M, i wsp.
Wydane: (2007)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
od: Pellagatti, A, i wsp.
Wydane: (2008)

The 5q- syndrome.
od: Giagounidis, A, i wsp.
Wydane: (2004)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
od: Pellagatti, A, i wsp.
Wydane: (2009)

Rapamycin Exacerbates Staphylococcus aureus Pneumonia by Inhibiting mTOR-RPS6 in Macrophages
od: Yu FY, i wsp.
Wydane: (2023-11-01)

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
od: Nikpour, M, i wsp.
Wydane: (2010)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
od: Pellagati, A, i wsp.
Wydane: (2008)

Endocrine responses and acute mTOR pathway phosphorylation to resistance exercise with leucine and whey
od: MT Lane, i wsp.
Wydane: (2017-02-01)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
od: Boultwood, J, i wsp.
Wydane: (2012)

5q- syndrome.
od: Boultwood, J, i wsp.
Wydane: (2012)

Embryonic Leucine Promotes Early Postnatal Growth via mTOR Signalling in Japanese Quails
od: Sawadi F. Ndunguru, i wsp.
Wydane: (2024-09-01)

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, i wsp.
Wydane: (2009)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
od: Fernandez-Mercado, M, i wsp.
Wydane: (2013)

YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, i wsp.
Wydane: (2009)

GENE COMPARISON STUDIES OF ERYTHROBLASTS DERIVED FROM DIFFERENT HAEMATOPOIETIC SOURCES
od: Merryweather-Clarke, A, i wsp.
Wydane: (2013)

Early leucine programming on protein utilization and mTOR signaling by DNA methylation in zebrafish (Danio rerio)
od: Qiang-Sheng Zhu, i wsp.
Wydane: (2020-08-01)

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes
od: Sundaravel, S, i wsp.
Wydane: (2012)

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes
od: Sundaravel, S, i wsp.
Wydane: (2012)

Comparative study of leucine on digestive enzyme secretion, ISR and mTOR pathway in cattle and porcine pancreas in vitro
od: Zhanhe Zhang, i wsp.
Wydane: (2024-12-01)

Ursolic acid inhibits leucine-stimulated mTORC1 signaling by suppressing mTOR localization to lysosome.
od: Xiang Ou, i wsp.
Wydane: (2014-01-01)

Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling
od: Ya-Jun Xie, i wsp.
Wydane: (2018-07-01)

Gene expression profiling in the myelodysplastic syndromes.
od: Pellagatti, A, i wsp.
Wydane: (2005)

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome.
od: Boultwood, J
Wydane: (2011)

Garland of Erythroblasts around a Macrophage: Erythroblastic Island
od: Chandan Kumar, i wsp.
Wydane: (2020-05-01)

Advances in the 5q- syndrome.
od: Boultwood, J, i wsp.
Wydane: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
od: Pellagatti, A, i wsp.
Wydane: (2005)

Erythroblast Enucleation
od: Ganesan Keerthivasan, i wsp.
Wydane: (2011-01-01)

Erythroblast enucleation
od: Anna Rita Migliaccio
Wydane: (2010-12-01)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH)
od: Esoof, N, i wsp.
Wydane: (2005)

Stimulation of erythroblast maturation in vitro by sphingolipids
od: R.B. Clayton, i wsp.
Wydane: (1974-11-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
od: Zhilin Zou, i wsp.
Wydane: (2020-03-01)

Leucine imparts cardioprotective effects by enhancing mTOR activity and mitochondrial fusion in a myocardial ischemia/reperfusion injury murine model
od: Atsushi Morio, i wsp.
Wydane: (2021-11-01)

L-Leucine Promotes STAT1 and ISGs Expression in TGEV-Infected IPEC-J2 Cells via mTOR Activation
od: Jian Du, i wsp.
Wydane: (2021-07-01)